The FDA has approved the booster dose of the vaccine against Covid-19 Johnson & Johnson. This decision comes after controversy that a dose of vaccine is less effective than previously thought.
The 19-member FDA panel voted unanimously Friday to recommend a second strike for the estimated 15 million people in the United States who have received the first dose of the J&J vaccine.
The day before, the panel recommended a third dose of the two-dose Moderna vaccine, and previously approved booster doses of Pfizer-BioNTech.
Nearly 10 million people have already received the booster dose of Pfizer in the US, where 188 million people, or about 57 percent of the population, have been fully vaccinated, according to data collected by the US Centers for Disease Control and Prevention (CDC).
J&J officials told the advisory panel on Friday that the second dose would help boost people’s immune defenses starting two to six months after their first dose.
To be part of the group »AOL“just click: Join Group and your request will be approved immediately.